Combitide 125 Inhaler 120mdi

Combitide 125 Inhaler 120mdi is used for the following:

• Long-term management and control of asthma.
• Preventing and controlling symptoms in asthma patients is not adequately managed by inhaled corticosteroids alone.
• Maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD).
• Reducing exacerbations in patients with COPD, including those suffering from chronic bronchitis and emphysema.

Administer Combitide 125 Inhaler 120mdi as instructed below:

• Shake the inhaler well for 5 seconds before each use.
• The medicine is meant for oral inhalation only.
• Use a spacer device if recommended by your doctor.
• If the inhaler hasn't been used for more than 7 days, release 2 test sprays into the air, away from your face, to ensure it's working properly.
• Consult your doctor for more specific use instructions.

Combitide 125 Inhaler 120mdi is administered via inhalation.

Combitide 125 Inhaler 120mdi comprises two active ingredients that work together to manage respiratory conditions:

• Fluticasone Propionate (125 mcg): This powerful corticosteroid has anti-inflammatory properties. By reducing inflammation and swelling in your airways, it helps you breathe easier.
• Salmeterol (25 mcg): This component acts as a long-acting beta2-adrenergic receptor agonist. It relaxes and widens the muscles of your bronchial airways, allowing more air to enter your lungs.

• Store your Combitide 125 Inhaler 120mdi at a controlled room temperature.
• Keep the inhaler upright with the mouthpiece facing downwards.
• Avoid puncturing the canister or exposing it to heat or flames.
• Always keep this medicine out of the reach of children.

• If you're using Combitide 125 Inhaler 120mdi for managing asthma or COPD, try to avoid exposure to allergens like dust and pollen, as they can trigger symptoms.
• Engage in light exercise like walking or yoga regularly, as it can aid in improving lung capacity. However, always consult your doctor before starting any new exercise routine.